Oh-Biologika-2023-08 Choriongonadotropin Alfa. The Health Insurance Companies Involved Are Pursuing The Goal Of Concluding Discount Agreements For The Active Ingredient Chorionic Gonadotropin Alfa With All Suitable Pharmaceutical Companies In Accordance With Section 130A (8) Sgb V. The Contract Is Concluded As Part Of The Openhousebiologika Procedure Of The Health Insurance Companies Involved: Individual Negotiations About Contract Content Are Not Conducted, Uniform Conditions Apply. The Cash Registers Involved Do Not Guarantee Individual Contractual Partners Any Exclusivity. The Contract Period Is A Maximum Of 24 Months Starting On June 1St, 2023. The Contract Ends On May 31, 2025 At The Latest, Regardless Of The Date Of The Conclusion Of The Contract. All Further Information Can Be Found In The Participation And Contract Documents.
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 63884348
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.